Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) and BioDelivery Sciences International, Inc. (NASDAQ: BDSI), announced today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

FBR Affirms BioDelivery Sciences (BDSI) at 'Outperform' Following FDA Approval of BELBUCA October 26, 2015 9:41 AM U.S. FDA Approves BELBUCA™ (buprenorphine) Buccal Film for Chronic Pain ManagementOctober 26, 2015 6:00 AM Valeant's looming M&A hiatus deals blow to investment banksOctober 23, 2015 1:21 AM Valeant vows to refute 'phantom sales' allegationsOctober 22, 2015 10:51 AM